Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)

BO Roep, S Thomaidou, R van Tienhoven… - Nature Reviews …, 2021 - nature.com
Type 1 diabetes mellitus is believed to result from destruction of the insulin-producing β-cells
in pancreatic islets that is mediated by autoimmune mechanisms. The classic view is that …

Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure

DL Eizirik, L Pasquali, M Cnop - Nature Reviews Endocrinology, 2020 - nature.com
Loss of functional β-cell mass is the key mechanism leading to the two main forms of
diabetes mellitus—type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) …

The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas

MA Atkinson, RG Mirmira - Cell Metabolism, 2023 - cell.com
Summary Type 1 diabetes (T1D) is widely considered to result from the autoimmune
destruction of insulin-producing β cells. This concept has been a central tenet for decades of …

Pathophysiology of type 1 diabetes and gut microbiota role

F Del Chierico, N Rapini, A Deodati… - International Journal of …, 2022 - mdpi.com
Type 1 diabetes (T1D) is a multifactorial autoimmune disease driven by T-cells against the
insulin-producing islet β-cells, resulting in a marked loss of β-cell mass and function …

Alterations in beta cell identity in type 1 and type 2 diabetes

ASM Moin, AE Butler - Current diabetes reports, 2019 - Springer
Abstract Purpose of Review To discuss the current understanding of “β cell identity” and
factors underlying altered identity of pancreatic β cells in diabetes, especially in humans …

Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis

ZJ Ward, JM Yeh, CL Reddy, A Gomber… - The lancet Diabetes & …, 2022 - thelancet.com
Background Previous studies of type 1 diabetes in childhood and adolescence have found
large variations in reported incidence around the world. However, it is unclear whether these …

Glucokinase activity in diabetes: too much of a good thing?

FM Ashcroft, M Lloyd, EA Haythorne - Trends in Endocrinology & …, 2023 - cell.com
Abstract Type 2 diabetes (T2D) is a global health problem characterised by chronic
hyperglycaemia due to inadequate insulin secretion. Because glucose must be metabolised …

Modulating the foreign body response of implants for diabetes treatment

BN Kharbikar, GS Chendke, TA Desai - Advanced drug delivery reviews, 2021 - Elsevier
Diabetes Mellitus is a group of diseases characterized by high blood glucose levels due to
patients' inability to produce sufficient insulin. Current interventions often require implants …

[HTML][HTML] An Integrated Map of Cell Type–Specific Gene Expression in Pancreatic Islets

RM Elgamal, P Kudtarkar, RL Melton, HM Mummey… - Diabetes, 2023 - Am Diabetes Assoc
Pancreatic islets consist of multiple cell types that produce hormones required for glucose
homeostasis, and islet dysfunction is a major factor in type 1 and type 2 diabetes. Numerous …

β‐Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes

H Ikegami, N Babaya, S Noso - Journal of Diabetes …, 2021 - Wiley Online Library
Diabetes mellitus is etiologically classified into type 1, type 2 and other types of diabetes.
Despite distinct etiologies and pathogenesis of these subtypes, many studies have …